Clinical trial
Development of a Newborn Screening Assay for Angelman Syndrome and Prader-Willi Syndrome
NCT05783791 is registered in ClinicalTrials.gov with University of Wisconsin, Madison as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Development of a Newborn Screening Assay for Angelman Syndrome and Prader-Willi Syndrome
- Lead sponsor
- University of Wisconsin, Madison
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 20, 2023
- Completion date
- July 21, 2023
- Enrollment
- 11 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.